BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 30249743)

  • 1. Comparative Analysis of the Capacity of the
    Willems HME; Lowes DJ; Barker KS; Palmer GE; Peters BM
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.
    Bruno VM; Shetty AC; Yano J; Fidel PL; Noverr MC; Peters BM
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa.
    Richardson JP; Willems HME; Moyes DL; Shoaie S; Barker KS; Tan SL; Palmer GE; Hube B; Naglik JR; Peters BM
    Infect Immun; 2018 Feb; 86(2):. PubMed ID: 29109176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidalysin Crucially Contributes to Nlrp3 Inflammasome Activation by Candida albicans Hyphae.
    Rogiers O; Frising UC; Kucharíková S; Jabra-Rizk MA; van Loo G; Van Dijck P; Wullaert A
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622184
    [No Abstract]   [Full Text] [Related]  

  • 5. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
    Chen Z; Jin J; Chen H; Chen Y; Feng S
    Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans.
    Roselletti E; Perito S; Gabrielli E; Mencacci A; Pericolini E; Sabbatini S; Cassone A; Vecchiarelli A
    Sci Rep; 2017 Dec; 7(1):17877. PubMed ID: 29259175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome.
    Lowes DJ; Hevener KE; Peters BM
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.
    Peters BM; Coleman BM; Willems HME; Barker KS; Aggor FEY; Cipolla E; Verma AH; Bishu S; Huppler AH; Bruno VM; Gaffen SL
    J Infect Dis; 2020 Apr; 221(9):1554-1563. PubMed ID: 31805183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of n-butanol alcohol extract of Baitouweng Decoction in treatment of vulvovaginal candidiasis based on negative regulation of NLRP3 inflammasome via PKCδ/NLRC4/IL-1Ra axis].
    Hu KF; Mo L; Zhang H; Xia D; Shi GX; Wu DQ; Wang TM; Shao J; Wang CZ
    Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1578-1588. PubMed ID: 37005846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.
    Pericolini E; Gabrielli E; Amacker M; Kasper L; Roselletti E; Luciano E; Sabbatini S; Kaeser M; Moser C; Hube B; Vecchiarelli A; Cassone A
    mBio; 2015 Jun; 6(3):e00724. PubMed ID: 26037125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".
    Yano J; Peters BM; Noverr MC; Fidel PL
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.
    Yano J; Noverr MC; Fidel PL
    mBio; 2017 Mar; 8(2):. PubMed ID: 28292981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.
    Nash EE; Peters BM; Lilly EA; Noverr MC; Fidel PL
    PLoS One; 2016; 11(1):e0147969. PubMed ID: 26807975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
    Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
    Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longdan Xiegan decoction ameliorates vulvovaginal candidiasis by inhibiting the NLRP3 inflammasome via the Toll-like receptor /MyD88 pathway.
    Feng X; Zhang H; Hu K; Shi G; Wu D; Shao J; Wang T; Wang C
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116869. PubMed ID: 37390876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesis.
    Valentine M; Rudolph P; Dietschmann A; Tsavou A; Mogavero S; Lee S; Priest EL; Zhurgenbayeva G; Jablonowski N; Timme S; Eggeling C; Allert S; Dolk E; Naglik JR; Figge MT; Gresnigt MS; Hube B
    mBio; 2024 Mar; 15(3):e0340923. PubMed ID: 38349176
    [No Abstract]   [Full Text] [Related]  

  • 17. Biofilms and vulvovaginal candidiasis.
    Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
    Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis.
    Peters BM; Palmer GE; Nash AK; Lilly EA; Fidel PL; Noverr MC
    Infect Immun; 2014 Feb; 82(2):532-43. PubMed ID: 24478069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent EGFR/MAPK-Mediated Immune Responses to Clinical
    Zhang J; Peng J; Li D; Mei H; Yu Y; Li X; She X; Liu W
    Front Immunol; 2022; 13():894069. PubMed ID: 35720274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.